Millennium Pharmaceuticals Inc – Product Pipeline Review

Global Markets Direct’s, ‘Millennium Pharmaceuticals Inc – Product Pipeline Review – 2016’, provides an overview of the Millennium Pharmaceuticals Inc’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Millennium Pharmaceuticals Inc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Millennium Pharmaceuticals Inc

The report provides overview of Millennium Pharmaceuticals Inc including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Millennium Pharmaceuticals Inc’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Millennium Pharmaceuticals Inc’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Millennium Pharmaceuticals Inc’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Millennium Pharmaceuticals Inc

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Millennium Pharmaceuticals Inc’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Millennium Pharmaceuticals Inc Snapshot 5

Millennium Pharmaceuticals Inc Overview 5

Key Facts 5

Millennium Pharmaceuticals Inc - Research and Development Overview 6

Key Therapeutic Areas 6

Millennium Pharmaceuticals Inc - Pipeline Review 11

Pipeline Products by Stage of Development 11

Pipeline Products - Monotherapy 12

Pipeline Products - Out-Licensed Products 13

Out-Licensed Products/Combination Treatment Modalities 14

Millennium Pharmaceuticals Inc - Pipeline Products Glance 15

Millennium Pharmaceuticals Inc - Clinical Stage Pipeline Products 15

Phase II Products/Combination Treatment Modalities 15

Phase I Products/Combination Treatment Modalities 16

Millennium Pharmaceuticals Inc - Early Stage Pipeline Products 17

Preclinical Products/Combination Treatment Modalities 17

Discovery Products/Combination Treatment Modalities 18

Millennium Pharmaceuticals Inc - Drug Profiles 19

alisertib - Drug Profile 19

Product Description 19

Mechanism Of Action 19

R&D Progress 19

bortezomib - Drug Profile 24

Product Description 24

Mechanism Of Action 24

R&D Progress 24

orteronel - Drug Profile 31

Product Description 31

Mechanism Of Action 31

R&D Progress 31

pevonedistat hydrochloride - Drug Profile 34

Product Description 34

Mechanism Of Action 34

R&D Progress 34

sapanisertib - Drug Profile 37

Product Description 37

Mechanism Of Action 37

R&D Progress 37

serabelisib - Drug Profile 40

Product Description 40

Mechanism Of Action 40

R&D Progress 40

Small Molecules to Inhibit Histone Deacetylase 6 for Oncology - Drug Profile 42

Product Description 42

Mechanism Of Action 42

R&D Progress 42

TAK-243 - Drug Profile 43

Product Description 43

Mechanism Of Action 43

R&D Progress 43

TAK-580 - Drug Profile 44

Product Description 44

Mechanism Of Action 44

R&D Progress 44

TAK-659 - Drug Profile 46

Product Description 46

Mechanism Of Action 46

R&D Progress 46

TAK-931 - Drug Profile 48

Product Description 48

Mechanism Of Action 48

R&D Progress 48

Millennium Pharmaceuticals Inc - Pipeline Analysis 49

Millennium Pharmaceuticals Inc - Pipeline Products by Target 49

Millennium Pharmaceuticals Inc - Pipeline Products by Route of Administration 51

Millennium Pharmaceuticals Inc - Pipeline Products by Molecule Type 52

Millennium Pharmaceuticals Inc - Pipeline Products by Mechanism of Action 53

Millennium Pharmaceuticals Inc - Dormant Projects 55

Millennium Pharmaceuticals Inc - Discontinued Pipeline Products 56

Discontinued Pipeline Product Profiles 57

alisertib 57

betrixaban 57

bortezomib 57

HuL-2G7 57

indusatumab vedotin 57

IPI-443 58

orteronel 58

TAK-441 58

TAK-733 58

TAK-901 58

TAK-960 58

tandutinib 58

Millennium Pharmaceuticals Inc - Locations And Subsidiaries 59

Head Office 59

Appendix 60

Methodology 60

Coverage 60

Secondary Research 60

Primary Research 60

Expert Panel Validation 60

Contact Us 60

Disclaimer 61

List of Tables

List of Tables

Millennium Pharmaceuticals Inc, Key Facts 5

Millennium Pharmaceuticals Inc – Pipeline by Indication, 2016 7

Millennium Pharmaceuticals Inc – Pipeline by Stage of Development, 2016 11

Millennium Pharmaceuticals Inc – Monotherapy Products in Pipeline, 2016 12

Millennium Pharmaceuticals Inc – Out-Licensed Products in Pipeline, 2016 13

Millennium Pharmaceuticals Inc – Out-Licensed Products/ Combination Treatment Modalities, 2016 14

Millennium Pharmaceuticals Inc – Phase II, 2016 15

Millennium Pharmaceuticals Inc – Phase I, 2016 16

Millennium Pharmaceuticals Inc – Preclinical, 2016 17

Millennium Pharmaceuticals Inc – Discovery, 2016 18

Millennium Pharmaceuticals Inc – Pipeline by Target, 2016 50

Millennium Pharmaceuticals Inc – Pipeline by Route of Administration, 2016 51

Millennium Pharmaceuticals Inc – Pipeline by Molecule Type, 2016 52

Millennium Pharmaceuticals Inc – Pipeline Products by Mechanism of Action, 2016 54

Millennium Pharmaceuticals Inc – Dormant Developmental Projects,2016 55

Millennium Pharmaceuticals Inc – Discontinued Pipeline Products, 2016 56

List of Figures

List of Figures

Millennium Pharmaceuticals Inc – Pipeline by Top 10 Indication, 2016 7

Millennium Pharmaceuticals Inc – Pipeline by Stage of Development, 2016 11

Millennium Pharmaceuticals Inc – Monotherapy Products in Pipeline, 2016 12

Millennium Pharmaceuticals Inc – Out-Licensed Products in Pipeline, 2016 13

Millennium Pharmaceuticals Inc – Pipeline by Top 10 Target, 2016 49

Millennium Pharmaceuticals Inc – Pipeline by Route of Administration, 2016 51

Millennium Pharmaceuticals Inc – Pipeline by Molecule Type, 2016 52

Millennium Pharmaceuticals Inc – Pipeline Products by Top 10 Mechanism of Action, 2016 53

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports